SCHEMBL20062835

SCHEMBL20062835

c1ccc2c(c1)sc1ccc(-c3cc4c(cc3-c3ccc5sc6ccccc6c5c3)-c3cc5c6ccccc6c6ccccc6c5cc3-c3cc(-c5ccc6sc7ccccc7c6c5)c(-c5ccc6sc7ccccc7c6c5)cc3-c3cc5c6ccccc6c6ccccc6c5cc3-4)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.50
ALOX5 P09917 1/20 0.43
ALDH1A1 P00352 5/20 0.42
MAPT P10636 4/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 1/20 0.40
CYP1A2 P05177 1/20 0.39
KDM4E B2RXH2 2/20 0.38
PTPN7 P35236 1/20 0.37
DUSP3 P51452 1/20 0.37
PTPN12 Q05209 1/20 0.37
PTPN22 Q9Y2R2 1/20 0.37
PIM3 Q86V86 1/20 0.36
PTGIR P43119 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20062781 0.97 GPR3 (0.47) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL20062836 0.88 GPR3 (0.48) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL18907472 0.88 GPR3 (0.48) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL20062843 0.88 GPR3 (0.48) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL20062833 0.88 GPR3 (0.48) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL16904388 0.87 GPR3 (0.52) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL20062762 0.86 GPR3 (0.47) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL20062751 0.86 GPR3 (0.47) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL20062765 0.86 GPR3 (0.47) GPR3ALOX5ALDH1A1MAPTRAB9A
SCHEMBL18907463 0.86 GPR3 (0.47) GPR3ALOX5ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10608185-B2 Organic electroluminescent materials and devices UNIVERAL DISPLAY CORPORATION (US) 2020-03-31 US disclosed
US-20180108844-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2018-04-19 US disclosed
US-20180108844-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180108844-A1 Organic Electroluminescent Materials and Devices SLCO4C1, SLCO2A1, SLCO2B1 GPR3 836/4885ALOX5 1559/4885ALDH1A1 1333/4885
US-10608185-B2 Organic electroluminescent materials and devices SLCO4C1, SLCO2A1, SLCO2B1 GPR3 836/4885ALOX5 1559/4885ALDH1A1 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.